80 related articles for article (PubMed ID: 18996083)
41. Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.
Saulle E; Riccioni R; Coppola S; Parolini I; Diverio D; Riti V; Mariani G; Laufer S; Sargiacomo M; Testa U
Br J Haematol; 2009 May; 145(3):399-411. PubMed ID: 19245429
[TBL] [Abstract][Full Text] [Related]
42. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis.
Kamoshita E; Ikeda Y; Fujita M; Amano H; Oikawa A; Suzuki T; Ogawa Y; Yamashina S; Azuma S; Narumiya S; Unno N; Majima M
Am J Pathol; 2006 Oct; 169(4):1458-72. PubMed ID: 17003499
[TBL] [Abstract][Full Text] [Related]
43. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth.
Amano H; Hayashi I; Endo H; Kitasato H; Yamashina S; Maruyama T; Kobayashi M; Satoh K; Narita M; Sugimoto Y; Murata T; Yoshimura H; Narumiya S; Majima M
J Exp Med; 2003 Jan; 197(2):221-32. PubMed ID: 12538661
[TBL] [Abstract][Full Text] [Related]
44. Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3.
Yamaki T; Endoh K; Miyahara M; Nagamine I; Thi Thu Huong N; Sakurai H; Pokorny J; Yano T
Cancer Lett; 2004 Oct; 214(1):115-20. PubMed ID: 15331179
[TBL] [Abstract][Full Text] [Related]
45. VEGF receptor protein-tyrosine kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2008 Oct; 375(3):287-91. PubMed ID: 18680722
[TBL] [Abstract][Full Text] [Related]
46. Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis.
Amano H; Ito Y; Suzuki T; Kato S; Matsui Y; Ogawa F; Murata T; Sugimoto Y; Senior R; Kitasato H; Hayashi I; Satoh Y; Narumiya S; Majima M
Cancer Sci; 2009 Dec; 100(12):2318-24. PubMed ID: 19799610
[TBL] [Abstract][Full Text] [Related]
47. Upregulation of soluble vascular endothelial growth factor receptor 1 contributes to angiogenesis defects in the placenta of alpha 2B-adrenoceptor deficient mice.
Muthig V; Gilsbach R; Haubold M; Philipp M; Ivacevic T; Gessler M; Hein L
Circ Res; 2007 Sep; 101(7):682-91. PubMed ID: 17673674
[TBL] [Abstract][Full Text] [Related]
48. The EP3 receptor stimulates ceramide and diacylglycerol release and inhibits growth of primary keratinocytes.
Konger RL; Brouxhon S; Partillo S; VanBuskirk J; Pentland AP
Exp Dermatol; 2005 Dec; 14(12):914-22. PubMed ID: 16274459
[TBL] [Abstract][Full Text] [Related]
49. Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns.
Bilson HA; Mitchell DL; Ashby B
FEBS Lett; 2004 Aug; 572(1-3):271-5. PubMed ID: 15304361
[TBL] [Abstract][Full Text] [Related]
50. A new mRNA splice variant coding for the human EP3-I receptor isoform.
Kotelevets L; Foudi N; Louedec L; Couvelard A; Chastre E; Norel X
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):195-201. PubMed ID: 18023986
[TBL] [Abstract][Full Text] [Related]
51. Critical roles of VEGF-C-VEGF receptor 3 in reconnection of the collecting lymph vessels in mice.
Ikomi F; Kawai Y; Nakayama J; Ogiwara N; Sasaki K; Mizuno R; Ohhashi T
Microcirculation; 2008 Oct; 15(7):591-603. PubMed ID: 18951277
[TBL] [Abstract][Full Text] [Related]
52. Increased expression of vascular endothelial growth factor and its receptor, Flt-1, in glomeruloid haemangioma associated with Crow-Fukase syndrome.
Yamamoto T; Yokozeki H
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):417-9. PubMed ID: 17309484
[No Abstract] [Full Text] [Related]
53. Prostanoids Regulate Angiogenesis and Lymphangiogenesis in Pathological Conditions.
Majima M; Matsuda Y; Watanabe SI; Ohtaki Y; Hosono K; Ito Y; Amano H
Cold Spring Harb Perspect Med; 2024 Apr; ():. PubMed ID: 38565267
[TBL] [Abstract][Full Text] [Related]
54. [Prostanoid receptors].
Negishi M
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):569-71. PubMed ID: 9081719
[No Abstract] [Full Text] [Related]
55. The EP3 Receptor: Exploring a New Target for Type 2 Diabetes Therapeutics.
Neuman JC; Kimple ME
J Endocrinol Diabetes Obes; 2013; 1(1):. PubMed ID: 26322320
[No Abstract] [Full Text] [Related]
56. Lipid Signaling in Ocular Neovascularization.
Terao R; Kaneko H
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635437
[TBL] [Abstract][Full Text] [Related]
57. Cellular density-dependent increases in HIF-1α compete with c-Myc to down-regulate human EP4 receptor promoter activity through Sp-1-binding region.
Seira N; Yamagata K; Fukushima K; Araki Y; Kurata N; Yanagisawa N; Mashimo M; Nakamura H; Regan JW; Murayama T; Fujino H
Pharmacol Res Perspect; 2018 Dec; 6(6):e00441. PubMed ID: 30455960
[TBL] [Abstract][Full Text] [Related]
58. PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice.
Leclerc JL; Lampert AS; Diller MA; Doré S
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1725-34. PubMed ID: 27084388
[TBL] [Abstract][Full Text] [Related]
59. The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice.
Ceddia RP; Lee D; Maulis MF; Carboneau BA; Threadgill DW; Poffenberger G; Milne G; Boyd KL; Powers AC; McGuinness OP; Gannon M; Breyer RM
Endocrinology; 2016 Jan; 157(1):220-32. PubMed ID: 26485614
[TBL] [Abstract][Full Text] [Related]
60. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
O'Callaghan G; Houston A
Br J Pharmacol; 2015 Nov; 172(22):5239-50. PubMed ID: 26377664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
